| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |